UK firms see shares jump on early Parkinson's data
This article was originally published in Scrip
Executive Summary
The UK biotechnology company Phytopharm saw its share price close up by more than 400% up yesterday (October 14th) at 26.95p on the back of early clinical and preclinical data from its Parkinson's disease drug candidate Cogane.